| Literature DB >> 34761531 |
Keith R Spangler1, Prasad Patil2, Xiaojing Peng2, Jonathan I Levy1, Kevin J Lane1, Koen F Tieskens1, Fei Carnes1, R Monina Klevens3, Elizabeth A Erdman4, T Scott Troppy3, M Patricia Fabian1, Jessica H Leibler1.
Abstract
BACKGROUND: The COVID-19 pandemic has highlighted the need for targeted local interventions given substantial heterogeneity within cities and counties. Publicly available case data are typically aggregated to the city or county level to protect patient privacy, but more granular data are necessary to identify and act upon community-level risk factors that can change over time.Entities:
Keywords: COVID-19; SARS-CoV-2; census tract; disparities; geocoding; race/ethnicity
Mesh:
Year: 2021 PMID: 34761531 PMCID: PMC8652977 DOI: 10.1111/irv.12926
Source DB: PubMed Journal: Influenza Other Respir Viruses ISSN: 1750-2640 Impact factor: 4.380
Descriptive statistics by phase of COVID‐19 cases, deaths, and average census tract characteristics in Massachusetts, USA
| Phase 1 (March–June 2020) | Phase 2 (September 2020 to February 2021) | |||||||
|---|---|---|---|---|---|---|---|---|
| Total cases | Non‐inst. cases | Total deaths | Non‐inst. deaths | Total cases | Non‐inst. cases | Total deaths | Non‐inst. deaths | |
|
| 98 898 | 79 348 | 7283 | 2696 | 406 318 | 393 551 | 6204 | 3535 |
|
| ||||||||
|
| 23.42% (6.05%) | 23.87% (6.06%) | 22.16% (5.69%) | 22.56% (6.06%) | 23.32% (5.93%) | 23.41% (5.92%) | 22.25% (5.44%) | 22.79% (5.68%) |
|
| 4.24% (2.8%) | 3.76% (2.4%) | 5.86% (3.33%) | 4.69% (2.96%) | 4.08% (2.53%) | 4.02% (2.46%) | 5.64% (3.46%) | 4.7% (2.94%) |
|
| 0.31% (0.77%) | 0.31% (0.79%) | 0.24% (0.61%) | 0.26% (0.65%) | 0.25% (0.71%) | 0.25% (0.71%) | 0.23% (0.66%) | 0.24% (0.67%) |
|
| 12.32% (17.28%) | 13.63% (18.4%) | 8.41% (13.34%) | 12.13% (17.88%) | 8.89% (13.63%) | 8.98% (13.77%) | 7.06% (11.9%) | 8.99% (14.46%) |
|
| 19.88% (21.97%) | 21.91% (22.93%) | 12.85% (17.35%) | 16.17% (19.64%) | 16.71% (20.51%) | 16.91% (20.68%) | 12.07% (16.47%) | 14.66% (18.65%) |
|
| 3.16% (2.6%) | 3.4% (2.65%) | 2.29% (1.97%) | 2.69% (2.16%) | 2.82% (2.35%) | 2.84% (2.36%) | 2.4% (2.03%) | 2.64% (2.19%) |
|
| 33.76% (7.64%) | 34.7% (7.3%) | 30.83% (7.55%) | 32.5% (7.48%) | 33.55% (7.15%) | 33.69% (7.05%) | 31.9% (7.22%) | 33.01% (7.05%) |
|
| 1.61 (2.83) | 0.95 (1.98) | 3.35 (3.71) | 1.28 (2.23) | 1.05 (2.08) | 0.96 (1.96) | 2.69 (3.47) | 1.25 (2.28) |
|
| 5.56% (5.58%) | 5.6% (5.51%) | 5.42% (5.76%) | 5.47% (5.54%) | 5.88% (7.77%) | 5.93% (7.86%) | 5.1% (5.11%) | 5.26% (5.25%) |
|
| 0.97% (1.46%) | 1.06% (1.52%) | 0.67% (1.15%) | 0.87% (1.32%) | 0.81% (1.32%) | 0.82% (1.33%) | 0.62% (1.08%) | 0.72% (1.17%) |
|
| 3526 (4112) | 3851 (4251) | 2476 (3554) | 3216 (4262) | 2943 (4063) | 2996 (4097.3) | 2130 (3115) | 2657 (3554) |
Reflects the number of cases and deaths that were successfully geocoded to a census tract (total number of individuals excluded due to lack of geocoding is 1360 [0.27%]).
FIGURE 1Incidence rate ratios (IRR) for census tract‐level factors included in the regression models for total cases (lighter blue, on left) and total deaths (darker blue, on right) by phase of the pandemic in Massachusetts (Phase 1: March–June 2020, Phase 2: September 2020 to February 2021). Inset for LTCF Beds variable provided to show IRRs for deaths, which are outside the scale of the other variables
FIGURE 2Incidence rate ratios (IRR) for census tract‐level factors included in the regression models for non‐institutional cases (lighter green, on left) and non‐institutional deaths (darker green, on right) by phase of the pandemic in Massachusetts (Phase 1: March–June 2020, Phase 2: September 2020 to February 2021). Non‐institutional cases and deaths are defined as confirmed COVID‐19 cases and deaths geolocated to an address not affiliated with a long‐term care facility, prison, or shelter
Incidence rate ratios (IRRs) for COVID‐19 cases and deaths in MA census tracts, by total and non‐institutional settings and phase of the pandemic
| COVID‐19 Cases Incidence Rate Ratios (95% Confidence Interval) | ||||
|---|---|---|---|---|
| Phase 1 | Phase 2 | |||
| Predictors | Total Cases | Non‐Inst. Cases | Total Cases | Non‐Inst. Cases |
|
| 0.95 (0.91, 0.99) | 0.95 (0.92, 0.98)^ | 0.96 (0.94, 0.98) | 0.98 (0.96, 1.00) |
|
| 1.01 (0.97, 1.05)^ | 1.02 (1.00, 1.05)^ | 0.98 (0.96, 1.00)^ | 0.99 (0.97, 1.01)^ |
|
| 1.02 (0.99, 1.04) | 1.01 (0.99, 1.03) | 1.01 (0.99, 1.02) | 1.00 (0.98, 1.01) |
|
| 1.20 (1.16, 1.24) | 1.22 (1.18, 1.25) | 1.04 (1.03, 1.06) | 1.03 (1.01, 1.05)^ |
|
| 1.37 (1.30, 1.44) | 1.36 (1.31, 1.42) | 1.16 (1.13, 1.19) | 1.13 (1.11, 1.16) |
|
| 1.06 (1.03, 1.09) | 1.05 (1.03, 1.08) | 1.03 (1.01, 1.04) | 1.02 (1.01, 1.04) |
|
| 1.08 (1.04, 1.11) | 1.13 (1.10, 1.17) | 1.09 (1.07, 1.11) | 1.13 (1.11, 1.15) |
|
|
|
|
|
|
|
| 0.83 (0.80, 0.86) | 0.83 (0.81, 0.86) | 0.93 (0.91, 0.94) | 0.92 (0.91, 0.94) |
|
| 1.01 (0.98, 1.04) | 1.00 (0.98, 1.02) | 0.99 (0.98, 1.01) | 0.99 (0.98, 1.01) |
|
| 0.95 (0.91, 0.99) | 0.95 (0.92, 0.98) | 0.96 (0.94, 0.98) | 0.98 (0.96, 1.00) |
Note: Bold values indicate non‐overlapping confidence intervals between total and non‐institutional outcomes (rows); carets (^) indicate non‐overlapping confidence intervals between cases and deaths within the same type of outcome (columns).